Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

Role of the factor VIII-binding capacity of endogenous von Willebrand factor on the development of factor VIII inhibitors in patients with severe hemophilia A.

Repessé Y, Costa C, Palla R, Farrokhi Moshai E, Borel-Derlon A, D'Oiron R, Rothschild C, El-Beshlawy A, Elalfy M, Ramanan V, Eshghi P, Oldenburg J, Pavlova A, Rosendaal FR, Peyvandi F, Kaveri SV, Lacroix-Desmazes S.

Haematologica. 2019 Jan 31. pii: haematol.2018.212001. doi: 10.3324/haematol.2018.212001. [Epub ahead of print]

2.

Prevention of the anti-factor VIII memory B-cell response by inhibition of the Bruton's tyrosine kinase in experimental hemophilia A.

Delignat S, Russick J, Gangadharan B, Rayes J, Ing M, Voorberg J, Kaveri SV, Lacroix-Desmazes S.

Haematologica. 2018 Dec 13. pii: haematol.2018.200279. doi: 10.3324/haematol.2018.200279. [Epub ahead of print]

3.

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.

Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2018 Dec 7. pii: S0091-6749(18)31733-0. doi: 10.1016/j.jaci.2018.10.064. [Epub ahead of print]

PMID:
30529242
4.

Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism.

Bozza S, Käsermann F, Kaveri SV, Romani L, Bayry J.

Eur J Immunol. 2019 Jan;49(1):195-198. doi: 10.1002/eji.201847774. Epub 2018 Oct 29.

PMID:
30267564
5.

Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune Diseases.

Bayry J, Kaveri SV.

Trends Pharmacol Sci. 2018 Nov;39(11):919-922. doi: 10.1016/j.tips.2018.08.004. Epub 2018 Sep 7. Review.

PMID:
30201270
6.

Catalytic antibodies in patients with systemic lupus erythematosus.

Pradhan V, Pandit P, Surve P, Lecerf M, Rajadhyaksha A, Nadkar M, Khadilkar PV, Chougule DA, Naigaonkar AA, Lacroix-Desmazes S, Bayry J, Ghosh K, Kaveri SV.

Eur J Rheumatol. 2018 Sep;5(3):173-178. doi: 10.5152/eurjrheum.2018.17194. Epub 2018 Aug 7.

7.

Inhibitor Formation in Congenital Hemophilia A: an Immunological Perspective.

Delignat S, Rayes J, Russick J, Kaveri SV, Lacroix-Desmazes S; ABIRISK consortium.

Semin Thromb Hemost. 2018 Sep;44(6):517-530. doi: 10.1055/s-0038-1657777. Epub 2018 Jun 4. Review.

PMID:
29864775
8.

Regulatory T cells induce activation rather than suppression of human basophils.

Sharma M, Das M, Stephen-Victor E, Galeotti C, Karnam A, Maddur MS, Bruneval P, Kaveri SV, Bayry J.

Sci Immunol. 2018 May 25;3(23). pii: eaan0829. doi: 10.1126/sciimmunol.aan0829.

PMID:
29802207
9.

Affinity kinetics of leptin-reactive immunoglobulins are associated with plasma leptin and markers of obesity and diabetes.

Bouhajja H, Bougacha-Elleuch N, Lucas N, Legrand R, Marrakchi R, Kaveri SV, Jamoussi K, Ayadi H, Abid M, Mnif-Feki M, Fetissov SO.

Nutr Diabetes. 2018 May 24;8(1):32. doi: 10.1038/s41387-018-0044-y.

10.

Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli.

Maddur MS, Kaveri SV, Bayry J.

Cell Mol Immunol. 2018 Dec;15(12):1074-1076. doi: 10.1038/s41423-018-0017-z. Epub 2018 Mar 22. No abstract available.

PMID:
29568116
11.

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

João C, Negi VS, Kazatchkine MD, Bayry J, Kaveri SV.

J Immunol. 2018 Mar 15;200(6):1957-1963. doi: 10.4049/jimmunol.1701271. Review.

12.

Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A.

Peyron I, Dimitrov JD, Delignat S, Gangadharan B, Srivastava A, Kaveri SV, Lacroix-Desmazes S.

Cell Immunol. 2018 Mar;325:64-68. doi: 10.1016/j.cellimm.2018.01.008. Epub 2018 Jan 31.

PMID:
29395036
13.

Natural Immunomodulators.

Ortuño-Sahagún D, Zänker K, Rawat AKS, Kaveri SV, Hegde P.

J Immunol Res. 2017;2017:7529408. doi: 10.1155/2017/7529408. Epub 2017 Dec 14. No abstract available.

14.

Complement C3 is a novel modulator of the anti-factor VIII immune response.

Rayes J, Ing M, Delignat S, Peyron I, Gilardin L, Vogel CW, Fritzinger DC, Frémeaux-Bacchi V, Kaveri SV, Roumenina LT, Lacroix-Desmazes S.

Haematologica. 2018 Feb;103(2):351-360. doi: 10.3324/haematol.2017.165720. Epub 2017 Nov 16.

15.

Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells.

Stephen-Victor E, Karnam A, Fontaine T, Beauvais A, Das M, Hegde P, Prakhar P, Holla S, Balaji KN, Kaveri SV, Latgé JP, Aimanianda V, Bayry J.

J Infect Dis. 2017 Dec 5;216(10):1281-1294. doi: 10.1093/infdis/jix469.

PMID:
28968869
16.

Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin.

Maddur MS, Kaveri SV, Bayry J.

Trends Immunol. 2017 Nov;38(11):789-792. doi: 10.1016/j.it.2017.08.008. Epub 2017 Sep 12.

PMID:
28916232
17.

Potential Predictive Role of Lipid Peroxidation Markers for Type 2 Diabetes in the Adult Tunisian Population.

Bouhajja H, Kacem FH, Abdelhedi R, Ncir M, Dimitrov JD, Marrakchi R, Jamoussi K, Rebai A, El Feki A, Abid M, Ayadi H, Kaveri SV, Mnif-Feki M, Bougacha-Elleuch N.

Can J Diabetes. 2018 Jun;42(3):263-271. doi: 10.1016/j.jcjd.2017.06.006. Epub 2017 Jul 19.

PMID:
28734952
18.

Methods for Posttranslational Induction of Polyreactivity of Antibodies.

Lecerf M, Jarossay A, Kaveri SV, Lacroix-Desmazes S, Dimitrov JD.

Methods Mol Biol. 2017;1643:135-145. doi: 10.1007/978-1-4939-7180-0_10.

PMID:
28667534
19.

IVIG-mediated effector functions in autoimmune and inflammatory diseases.

Galeotti C, Kaveri SV, Bayry J.

Int Immunol. 2017 Dec 30;29(11):491-498. doi: 10.1093/intimm/dxx039. Review.

PMID:
28666326
20.

Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.

Saha C, Das M, Patil V, Stephen-Victor E, Sharma M, Wymann S, Jordi M, Vonarburg C, Kaveri SV, Bayry J.

Front Immunol. 2017 Mar 14;8:275. doi: 10.3389/fimmu.2017.00275. eCollection 2017.

21.

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.

Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, Rabin M, Trinath J, Balaji KN, Bolgert F, Vallat JM, Magy L, Kaveri SV, Bayry J.

J Neuroinflammation. 2017 Mar 20;14(1):58. doi: 10.1186/s12974-017-0818-5.

22.

Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs.

Stephen-Victor E, Das M, Sharma M, Galeotti C, Fohrer-Ting H, Sendid B, Darnige L, Terris B, Badoual C, Bruneval P, Kaveri SV, Bayry J.

Haematologica. 2017 Jun;102(6):e233-e237. doi: 10.3324/haematol.2016.163451. Epub 2017 Feb 16. No abstract available.

23.

Human basophils may not undergo modulation by DC-SIGN and mannose receptor-targeting immunotherapies due to absence of receptors.

Das M, Galeotti C, Stephen-Victor E, Karnam A, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2017 Apr;139(4):1403-1404.e1. doi: 10.1016/j.jaci.2016.09.062. Epub 2017 Jan 11. No abstract available.

PMID:
28088336
24.

Multitarget selection of catalytic antibodies with β-lactamase activity using phage display.

Shahsavarian MA, Chaaya N, Costa N, Boquet D, Atkinson A, Offmann B, Kaveri SV, Lacroix-Desmazes S, Friboulet A, Avalle B, Padiolleau-Lefèvre S.

FEBS J. 2017 Feb;284(4):634-653. doi: 10.1111/febs.14012. Epub 2017 Feb 6.

25.

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis.

Stephen-Victor E, Sharma VK, Das M, Karnam A, Saha C, Lecerf M, Galeotti C, Kaveri SV, Bayry J.

Front Immunol. 2016 Nov 4;7:465. eCollection 2016.

26.

Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way.

Shopsin B, Kaveri SV, Bayry J.

Cell Host Microbe. 2016 Nov 9;20(5):555-557. doi: 10.1016/j.chom.2016.10.018.

27.

The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.

Gangadharan B, Ing M, Delignat S, Peyron I, Teyssandier M, Kaveri SV, Lacroix-Desmazes S.

Haematologica. 2017 Feb;102(2):271-281. doi: 10.3324/haematol.2016.148502. Epub 2016 Oct 6.

28.

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease.

Galeotti C, Kaveri SV, Cimaz R, Koné-Paut I, Bayry J.

Drug Discov Today. 2016 Nov;21(11):1850-1857. doi: 10.1016/j.drudis.2016.08.004. Epub 2016 Aug 6. Review.

PMID:
27506874
29.

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.

Saha C, Das M, Stephen-Victor E, Friboulet A, Bayry J, Kaveri SV.

Molecules. 2016 Jul 14;21(7). pii: E912. doi: 10.3390/molecules21070912.

30.

Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion.

Holla S, Stephen-Victor E, Prakhar P, Sharma M, Saha C, Udupa V, Kaveri SV, Bayry J, Balaji KN.

Sci Rep. 2016 Apr 15;6:24193. doi: 10.1038/srep24193.

31.

Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.

Mahendra A, Peyron I, Thaunat O, Dollinger C, Gilardin L, Sharma M, Wootla B, Rao DN, Padiolleau-Lefevre S, Boquet D, More A, Varadarajan N, Kaveri SV, Legendre C, Lacroix-Desmazes S.

J Immunol. 2016 May 15;196(10):4075-81. doi: 10.4049/jimmunol.1403005. Epub 2016 Apr 11.

32.

The Homophilic Domain - An Immunological Archetype.

Kohler H, Bayry J, Kaveri SV.

Front Immunol. 2016 Mar 21;7:106. doi: 10.3389/fimmu.2016.00106. eCollection 2016. Review.

33.

Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.

Galeotti C, Hegde P, Das M, Stephen-Victor E, Canale F, Muñoz M, Sharma VK, Dimitrov JD, Kaveri SV, Bayry J.

Sci Rep. 2016 Jan 22;6:19592. doi: 10.1038/srep19592.

34.

Association of clinical presentation with anti-nuclear antibody specificities among patients with systemic lupus erythematosus.

Pradhan V, Patwardhan M, Rajadhyksha A, Umare V, Khadilkar P, Kaveri SV, Ghosh K.

Indian J Nephrol. 2015 Nov-Dec;25(6):391-2. doi: 10.4103/0971-4065.160338. No abstract available.

35.

Impaired regulatory T cell function in autoimmune diseases: are microRNAs the culprits?

Sharma VK, Kaveri SV, Bayry J.

Cell Mol Immunol. 2016 Mar;13(2):135-7. doi: 10.1038/cmi.2015.98. Epub 2015 Dec 14. No abstract available.

36.

Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody.

Gupta N, de Wispelaere M, Lecerf M, Kalia M, Scheel T, Vrati S, Berek C, Kaveri SV, Desprès P, Lacroix-Desmazes S, Dimitrov JD.

Sci Rep. 2015 Nov 6;5:16248. doi: 10.1038/srep16248.

37.

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

Brito-Zerón P, Gheitasi H, Retamozo S, Bové A, Londoño M, Sánchez-Tapias JM, Caballero M, Kostov B, Forns X, Kaveri SV, Ramos-Casals M.

Arthritis Res Ther. 2015 Sep 10;17:250. doi: 10.1186/s13075-015-0766-3.

38.

Cross-presentation of antigens by dendritic cells: role of autophagy.

Das M, Kaveri SV, Bayry J.

Oncotarget. 2015 Oct 6;6(30):28527-8. doi: 10.18632/oncotarget.5268. No abstract available.

39.

Natural and Induced Antibody Polyreactivity.

Jarossay A, Hadzhieva M, Kaveri SV, Lacroix-Desmazes S, Dimitrov JD.

Anticancer Agents Med Chem. 2015;15(10):1230-41.

PMID:
26179269
40.

Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.

Stepanov AV, Belogurov AA Jr, Kothapalli P, Shamborant OG, Knorre VD, Telegin GB, Ovsepyan AA, Ponomarenko NA, Deyev SM, Kaveri SV, Gabibov AG.

Acta Naturae. 2015 Apr-Jun;7(2):74-9.

41.

IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.

Bayry J, Hartung HP, Kaveri SV.

Trends Pharmacol Sci. 2015 Jul;36(7):419-21. doi: 10.1016/j.tips.2015.04.012. Epub 2015 May 20.

PMID:
26003802
42.

Correction to Mechanism and functional implications of the heme-induced binding promiscuity of IgE.

Hadzhieva M, Vassilev TL, Roumenina LT, Bayry J, Kaveri SV, Lacroix-Desmazes S, Dimitrov JD.

Biochemistry. 2015 Apr 14;54(14):2399. doi: 10.1021/acs.biochem.5b00323. Epub 2015 Apr 3. No abstract available.

PMID:
25839915
43.

Mechanism and functional implications of the heme-induced binding promiscuity of IgE.

Hadzhieva M, Vassilev TL, Roumenina LT, Bayry J, Kaveri SV, Lacroix-Desmazes S, Dimitrov JD.

Biochemistry. 2015 Mar 24;54(11):2061-72. doi: 10.1021/bi501507m. Epub 2015 Mar 11. Erratum in: Biochemistry. 2015 Apr 14;54(14):2399.

PMID:
25742488
44.

Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance.

Gupta N, Culina S, Meslier Y, Dimitrov J, Arnoult C, Delignat S, Gangadharan B, Lecerf M, Justesen S, Gouilleux-Gruart V, Salomon BL, Scott DW, Kaveri SV, Mallone R, Lacroix-Desmazes S.

Sci Transl Med. 2015 Feb 18;7(275):275ra21. doi: 10.1126/scitranslmed.aaa1957.

PMID:
25696000
45.

Molecular and immunological biomarkers to predict IVIg response.

Galeotti C, Kaveri SV, Bayry J.

Trends Mol Med. 2015 Mar;21(3):145-7. doi: 10.1016/j.molmed.2015.01.005. Epub 2015 Feb 10.

PMID:
25680699
46.

Intravenous immunoglobulin as clinical immune-modulating therapy.

Gilardin L, Bayry J, Kaveri SV.

CMAJ. 2015 Mar 3;187(4):257-64. doi: 10.1503/cmaj.130375. Epub 2015 Feb 9. Review. No abstract available.

47.

Viscum album-mediated COX-2 inhibition implicates destabilization of COX-2 mRNA.

Saha C, Hegde P, Friboulet A, Bayry J, Kaveri SV.

PLoS One. 2015 Feb 9;10(2):e0114965. doi: 10.1371/journal.pone.0114965. eCollection 2015.

48.

Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Lecerf M, Scheel T, Pashov AD, Jarossay A, Ohayon D, Planchais C, Mesnage S, Berek C, Kaveri SV, Lacroix-Desmazes S, Dimitrov JD.

J Biol Chem. 2015 Feb 20;290(8):5203-13. doi: 10.1074/jbc.M114.618124. Epub 2015 Jan 6.

49.

Intravenous immunoglobulin and immune response.

Kaveri SV, Lecerf M, Saha C, Kazatchkine MD, Lacroix-Desmazes S, Bayry J.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:94-6. doi: 10.1111/cei.12526. No abstract available.

50.

Basophils are inept at promoting human Th17 responses.

Sharma M, Stephen-Victor E, Poncet P, Kaveri SV, Bayry J.

Hum Immunol. 2015 Mar;76(2-3):176-80. doi: 10.1016/j.humimm.2014.12.015. Epub 2014 Dec 16. Erratum in: Hum Immunol. 2015 Jun;76(6):467.

PMID:
25526920

Supplemental Content

Loading ...
Support Center